Unraveling the mechanisms of IVIG immunotherapy in MIS-C

In The Journal of Clinical Investigation, Zhu et al. report that intravenous immunoglobulin (IVIG) targets IL-1β+ neutrophils to exert anti-inflammatory effects in Multisystem Inflammatory Syndrome in Children (MIS-C), a post-infectious inflammatory condition associated with the COVID-19.